• No results found

University of Groningen Endothelial plasticity in fibrosis and epigenetics as a therapeutic target Hulshoff, Melanie

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Endothelial plasticity in fibrosis and epigenetics as a therapeutic target Hulshoff, Melanie"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Endothelial plasticity in fibrosis and epigenetics as a therapeutic target

Hulshoff, Melanie

DOI:

10.33612/diss.146265795

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Hulshoff, M. (2020). Endothelial plasticity in fibrosis and epigenetics as a therapeutic target. University of Groningen. https://doi.org/10.33612/diss.146265795

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions accompanying the PhD thesis

Endothelial plasticity in fibrosis and epigenetics as a therapeutic target

By

Melanie S. Hulshoff

1) Endothelial plasticity is regulated by epigenetic modifications (this thesis).

2) Standardization of in vitro models of EndMT is essential to identify the underlying epigenetic mechanisms of EndMT (this thesis).

3) Unraveling the underlying epigenetic mechanisms of EndMT depends on the development of in vivo models of EndMT (this thesis).

4) A cure for fibrosis depends on epigenetic targeting (this thesis). 5) Fibroblasts are not derived from EndMT (Moore-Morris et al).

6) Vaccines tailored to the coronavirus (SARS-CoV-2) do not offer protection against novel coronaviruses (Giurgea et al).

7) Epigenetic alterations play an underestimated role in the onset of coronavirus disease complications (Khan et al).

8) Education is the difference between wishing you could help others and being able to help them (Russel M. Nelson).

Referenties

GERELATEERDE DOCUMENTEN

TGF-β1 treatment in human coronary endothelial cells resulted in aberrant promoter methylation and thereby reduced gene expression of RASAL1 (RAS protein activator like 1

(K) qRT-PCR data showing mRNA expression of the key EndMT transcription factors (SNAIL, SLUG, and TWIST) in DNMT3a siRNA transfected cells as compared to scrambled control

Indeed, as we have reviewed, non-coding RNAs interact with EndMT transcription factors, plus endothelial and mesenchymal genes and signaling pathways, ascribing them a likely

(F) qPCR analysis showing an increased expression of endothelial marker gene CD31 and decreased expression of EndMT transcriptional factors Snail, Slug and Twist upon treatment

Both FGF23 and Klotho are phospho-regulatory hormones, and, as discussed in detail earlier, although numerous studies corroborated their relevance on cardiovascular morbidity,

These dCas derivatives consist of an endonuclease-deficient Cas9 which can be fused to different effector domains to perform distinct in vitro applications such as

Bisulfite sequencing analysis showing the methylation status of CpGs in two different regions (region 1: from -375 bp to -87 bp; region 2: from -74 bp to +96 bp) within the

Different components such as inflammation but also EndMT and non-coding RNAs are potential regulators which facilitate chronic kidney disease-induced cardiac fibrosis. In Chapter